Editorial
Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes
Abstract
Type 2 diabetes mellitus is a powerful cardiovascular (CV) risk factor (1). Diabetic patients have a 2- to 4-times increased CV risk and about 80% of them die from CV disease (CVD) (1-3).
